BACKGROUND: Delayed antibiotic prescribing is promoted as a strategy to reduce antibiotic consumption, but its use and its effect on antibiotic consumption in routine care is poorly described. AIM: To quantify delayed antibiotic prescribing in adults presenting in primary care with acute cough/lower respiratory tract infection (LRTI), duration of advised delay, consumption of delayed antibiotics, and factors associated with consumption. DESIGN AND SETTING: Prospective observational cohort in general practices in 14 primary care networks in 13 European countries. METHOD: GPs recorded clinical features and antibiotic prescribing for adults presenting with an acute infective illness with cough as the dominant symptom. Patients recorded their consumption of antibiotics from any source during the 28-day follow up. RESULTS: Two hundred and ten (6.3%) of 3368 patients with usable consultation data were prescribed delayed antibiotics. The median recommended delay period was 3 days. Seventy-five (44.4%) of the 169 with consumption data consumed the antibiotic course and a further 18 (10.7%) took another antibiotic during the study period. 50 (29.6%) started their delayed course on the day of prescription. Clinician diagnosis of upper respiratory tract/viral infection and clinician's perception of patient's wanting antibiotics were associated with less consumption of the delayed prescription. Patient's wanting antibiotics was associated with greater consumption. CONCLUSION: Delayed antibiotic prescribing was used infrequently for adults presenting in general practice with acute cough/LRTI. When used, the effect on antibiotic consumption was less than found in most trials. There are opportunities for standardising the intervention and promoting wider uptake.
BACKGROUND: Delayed antibiotic prescribing is promoted as a strategy to reduce antibiotic consumption, but its use and its effect on antibiotic consumption in routine care is poorly described. AIM: To quantify delayed antibiotic prescribing in adults presenting in primary care with acute cough/lower respiratory tract infection (LRTI), duration of advised delay, consumption of delayed antibiotics, and factors associated with consumption. DESIGN AND SETTING: Prospective observational cohort in general practices in 14 primary care networks in 13 European countries. METHOD: GPs recorded clinical features and antibiotic prescribing for adults presenting with an acute infective illness with cough as the dominant symptom. Patients recorded their consumption of antibiotics from any source during the 28-day follow up. RESULTS: Two hundred and ten (6.3%) of 3368 patients with usable consultation data were prescribed delayed antibiotics. The median recommended delay period was 3 days. Seventy-five (44.4%) of the 169 with consumption data consumed the antibiotic course and a further 18 (10.7%) took another antibiotic during the study period. 50 (29.6%) started their delayed course on the day of prescription. Clinician diagnosis of upper respiratory tract/viral infection and clinician's perception of patient's wanting antibiotics were associated with less consumption of the delayed prescription. Patient's wanting antibiotics was associated with greater consumption. CONCLUSION: Delayed antibiotic prescribing was used infrequently for adults presenting in general practice with acute cough/LRTI. When used, the effect on antibiotic consumption was less than found in most trials. There are opportunities for standardising the intervention and promoting wider uptake.
Authors: Robert M Siegel; Michele Kiely; James P Bien; Evelyn C Joseph; James B Davis; Sandra G Mendel; John P Pestian; Thomas G DeWitt Journal: Pediatrics Date: 2003-09 Impact factor: 7.124
Authors: David Gillespie; Daniel Farewell; Lucy Brookes-Howell; Christopher C Butler; Samuel Coenen; Nick A Francis; Paul Little; Beth Stuart; Theo Verheij; Kerenza Hood Journal: Patient Prefer Adherence Date: 2017-03-15 Impact factor: 2.711
Authors: Mia Tyrstrup; Alike van der Velden; Sven Engstrom; Geert Goderis; Sigvard Molstad; Theo Verheij; Samuel Coenen; Niels Adriaenssens Journal: Scand J Prim Health Care Date: 2017-03-03 Impact factor: 2.581
Authors: Erika A Saliba-Gustafsson; Michael A Borg; Senia Rosales-Klintz; Anna Nyberg; Cecilia StålsbyLundborg Journal: BMJ Open Date: 2017-09-24 Impact factor: 2.692
Authors: Cliodna A M McNulty; Donna M Lecky; Meredith K D Hawking; Anna Quigley; Chris C Butler Journal: BMJ Open Date: 2015-11-27 Impact factor: 2.692